» Articles » PMID: 30674322

Serum Protein Signature of Coronary Artery Disease in Type 2 Diabetes Mellitus

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2019 Jan 25
PMID 30674322
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Coronary artery disease (CAD) is the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). The purpose of the present study was to discriminate the Indian CAD patients with or without T2DM by using multiple pathophysiological biomarkers.

Methods: Using sensitive multiplex protein assays, we assessed 46 protein markers including cytokines/chemokines, metabolic hormones, adipokines and apolipoproteins for evaluating different pathophysiological conditions of control, T2DM, CAD and T2DM with CAD patients (T2DM_CAD). Network analysis was performed to create protein-protein interaction networks by using significantly (p < 0.05) altered protein markers in each disease using STRING 10.5 database. We used two supervised analysis methods i.e., between class analysis (BCA) and principal component analysis (PCA) to reveals distinct biomarkers profiles. Further, random forest classification (RF) was used to classify the diseases by the panel of markers.

Results: Our two supervised analysis methods BCA and PCA revealed a distinct biomarker profiles and high degree of variability in the marker profiles for T2DM_CAD and CAD. Thereafter, the present study identified multiple potential biomarkers to differentiate T2DM, CAD, and T2DM_CAD patients based on their relative abundance in serum. RF classified T2DM based on the abundance patterns of nine markers i.e., IL-1β, GM-CSF, glucagon, PAI-I, rantes, IP-10, resistin, GIP and Apo-B; CAD by 14 markers i.e., resistin, PDGF-BB, PAI-1, lipocalin-2, leptin, IL-13, eotaxin, GM-CSF, Apo-E, ghrelin, adipsin, GIP, Apo-CII and IP-10; and T2DM _CAD by 12 markers i.e., insulin, resistin, PAI-1, adiponectin, lipocalin-2, GM-CSF, adipsin, leptin, Apo-AII, rantes, IL-6 and ghrelin with respect to the control subjects. Using network analysis, we have identified several cellular network proteins like PTPN1, AKT1, INSR, LEPR, IRS1, IRS2, IL1R2, IL6R, PCSK9 and MYD88, which are responsible for regulating inflammation, insulin resistance, and atherosclerosis.

Conclusion: We have identified three distinct sets of serum markers for diabetes, CAD and diabetes associated with CAD in Indian patients using nonparametric-based machine learning approach. These multiple marker classifiers may be useful for monitoring progression from a healthy person to T2DM and T2DM to T2DM_CAD. However, these findings need to be further confirmed in the future studies with large number of samples.

Citing Articles

Insights into the molecular underpinning of type 2 diabetes complications.

Singh A, Bocher O, Zeggini E Hum Mol Genet. 2025; 34(6):469-480.

PMID: 39807636 PMC: 11891870. DOI: 10.1093/hmg/ddae203.


Artificial Intelligence in Cardiology and Atherosclerosis in the Context of Precision Medicine: A Scoping Review.

Kolaszynska O, Lorkowski J Appl Bionics Biomech. 2024; 2024:2991243.

PMID: 38715681 PMC: 11074834. DOI: 10.1155/2024/2991243.


Reevaluating Adiponectin's impact on obesity hypertension: a Chinese case-control study.

Wu O, Lu X, Leng J, Zhang X, Liu W, Yang F BMC Cardiovasc Disord. 2024; 24(1):208.

PMID: 38615012 PMC: 11015577. DOI: 10.1186/s12872-024-03865-4.


Systems Biology: New Insight into Antibiotic Resistance.

Francine P Microorganisms. 2022; 10(12).

PMID: 36557614 PMC: 9781975. DOI: 10.3390/microorganisms10122362.


Abnormal glucose regulation in Chinese patients with coronary artery disease: a gender analysis.

Liu J, He L, Zhu W, Duan G, Fang Y, Feng Y J Cardiothorac Surg. 2022; 17(1):94.

PMID: 35505380 PMC: 9066952. DOI: 10.1186/s13019-022-01848-0.


References
1.
Schultz J, Verstuyft J, Gong E, NICHOLS A, Rubin E . Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature. 1993; 365(6448):762-4. DOI: 10.1038/365762a0. View

2.
Lalic K, Jotic A, Rajkovic N, Singh S, Stosic L, Popovic L . Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity. Int J Endocrinol. 2015; 2015:390185. PMC: 4451778. DOI: 10.1155/2015/390185. View

3.
De Rosa S, Cirillo P, Pacileo M, di Palma V, Paglia A, Chiariello M . Leptin stimulated C-reactive protein production by human coronary artery endothelial cells. J Vasc Res. 2009; 46(6):609-17. DOI: 10.1159/000226229. View

4.
Sahu S, Ganguly R, Raman P . Leptin augments recruitment of IRF-1 and CREB to thrombospondin-1 gene promoter in vascular smooth muscle cells in vitro. Am J Physiol Cell Physiol. 2016; 311(2):C212-24. DOI: 10.1152/ajpcell.00068.2016. View

5.
Herder C, Haastert B, Muller-Scholze S, Koenig W, Thorand B, Holle R . Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Diabetes. 2005; 54 Suppl 2:S11-7. DOI: 10.2337/diabetes.54.suppl_2.s11. View